|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 471/04 | (2006.01) |
| A61K 31/519 | (2006.01) | ||
| A61P 29/00 | (2006.01) |
| (11) | Number of the document | 3372605 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18151233.6 |
| Date of filing the European patent application | 2009-10-21 | |
| (97) | Date of publication of the European application | 2018-09-12 |
| (45) | Date of publication and mention of the grant of the patent | 2021-11-03 |
| (46) | Date of publication of the claims translation | 2022-02-10 |
| (30) | Number | Date | Country code |
| 107616 P | 2008-10-22 | US |
| (72) |
HAAS, Julia , US
ANDREWS, Steven, W. , US
JIANG, Yutong , US
ZHANG, Gan , US
|
| (73) |
Array Biopharma, Inc. ,
3200 Walnut Street, Boulder, CO 80301,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Pakeistieji pirazolo[1,5-a]pirimidino junginiai, kaip Trk kinazės inhibitoriai |
| SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE COMPOUNDS AS TRK KINASE INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2022-10-17 | 14 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-10-21 |